✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-023 min read

Can GLP-1 Medications Help Prevent Type 2 Diabetes?

Weight loss and better blood sugar can lower diabetes risk for people with prediabetes. The honest, evidence-based answer.

A coastal stroll in golden-hour light

The short answer

For people with prediabetes and excess weight, losing weight and improving blood sugar can lower the risk of progressing to type 2 diabetes, and GLP-1 medications produce significant weight loss. This is supportive, physician-guided care, not a guarantee, and it does not replace lifestyle changes.

Why it can help

Excess weight and insulin resistance drive the progression from prediabetes to type 2 diabetes. In STEP 1 (PMID 33567185), semaglutide produced about 14.9% average weight loss; meaningful weight loss generally improves blood-sugar markers. A physician decides whether it is appropriate for you.

Ready to start?

$199 Skeptics' Trial, see if it works for you

One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.

Start the 30-day trial

The honest limits

GLP-1 medications are not a vaccine against diabetes; risk depends on genetics, weight, activity, and more. Compounded versions are not FDA-approved or studied in trials, so prevention claims cannot be made for them specifically. This is general education, not medical advice.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Take the free 2-minute quiz or call (657) 837-3342

Frequently asked questions

Can semaglutide prevent diabetes?

For people with prediabetes and excess weight, losing weight and improving blood sugar can lower the risk of progressing to type 2 diabetes. It is supportive, physician-guided care, not a guarantee.

How does weight loss lower diabetes risk?

Excess weight and insulin resistance drive progression to type 2 diabetes. Meaningful weight loss (about 14.9% average on semaglutide in STEP 1, PMID 33567185) generally improves blood-sugar markers.

Is this an FDA-approved use?

Talk to your physician about indications. Compounded versions are not FDA-approved or studied in trials, so prevention claims cannot be made for them specifically.

Do I still need lifestyle changes?

Yes. Medication supports, it does not replace, nutrition, activity, and sleep. Risk depends on many factors.

How does New Hope approach prediabetes?

Dr. Sharma reviews your labs and risk factors and decides what is appropriate. Compounded medications are not FDA-approved.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Not ready to start? Get the details by email.

Pricing, how it works, and what to expect, sent to your inbox. No pressure, unsubscribe anytime.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.